{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:07:26Z","timestamp":1774411646057,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.neurol.2026.01.002","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:26:16Z","timestamp":1769516776000},"page":"155-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["EPIGAME a vignette-based study of management practices of medication overuse in migraine, among French neurologists"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7541-6916","authenticated-orcid":false,"given":"C.","family":"Lucas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Revol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Faist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Defawe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6717-9234","authenticated-orcid":false,"given":"M.","family":"Lanteri Minet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neurol.2026.01.002_bib0170","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s40263-021-00818-9","article-title":"The evolution of medication overuse headache: history, pathophysiology and clinical update","volume":"35","author":"Sun-Edelstein","year":"2021","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.neurol.2026.01.002_bib0175","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pain.2011.08.018","article-title":"Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Tr\u00f8ndelag Health Studies","volume":"153","author":"Hagen","year":"2012","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.neurol.2026.01.002_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"The international classification of headache disorders, 3rd edition","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"issue":"12","key":"10.1016\/j.neurol.2026.01.002_bib0185","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1212\/WNL.0000000000004371","article-title":"Medication overuse headache: an entrenched idea in need of scrutiny","volume":"89","author":"Scher","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurol.2026.01.002_bib0190","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/head.13785","article-title":"The many faces of medication-overuse headache in clinical practice","volume":"60","author":"Vandenbussche","year":"2020","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.neurol.2026.01.002_bib0195","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/0333102413512033","article-title":"Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review","volume":"34","author":"Westergaard","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2026.01.002_bib0200","first-page":"163","article-title":"Management of chronic daily headache in migraine patient: medication overuse headache and chronic migraine. French guidelines (French Headache Society, French Private Neurologists Association, French Pain Society)","volume":"27","author":"Lant\u00e9ri-Minet","year":"2014","journal-title":"Douleur Analgesie"},{"issue":"5","key":"10.1016\/j.neurol.2026.01.002_bib0205","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","article-title":"The cost of headache disorders in Europe: the Eurolight project","volume":"19","author":"Linde","year":"2012","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2026.01.002_bib0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/head.12970","article-title":"Medication-overuse headache: protocols and outcomes in 149 consecutive patients in a tertiary brazilian headache center","volume":"57","author":"Krymchantowski","year":"2017","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.neurol.2026.01.002_bib0215","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/0333102411431309","article-title":"Detoxification for medication overuse headache is the primary task","volume":"32","author":"Olesen","year":"2012","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1016\/j.neurol.2026.01.002_bib0220","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/ene.14268","article-title":"European Academy of Neurology guideline on the management of medication-overuse headache","volume":"27","author":"Diener","year":"2020","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2026.01.002_bib0225","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(19)30146-2","article-title":"Pathophysiology, prevention, and treatment of medication overuse headache","volume":"18","author":"Diener","year":"2019","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2026.01.002_bib0230","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jamaneurol.2020.1179","article-title":"Comparison of 3 treatment strategies for medication overuse headache: a randomized clinical trial","volume":"77","author":"Carlsen","year":"2020","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2026.01.002_bib0235","first-page":"404","article-title":"Recommandations 2021 pour le diagnostic et la prise en charge de la migraine chez l\u2019adulte\u00a0: traitement des crises","volume":"3","author":"Donnet","year":"2022","journal-title":"Presse Med Form"},{"issue":"13","key":"10.1016\/j.neurol.2026.01.002_bib0240","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.283.13.1715","article-title":"Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality","volume":"283","author":"Peabody","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.neurol.2026.01.002_bib0245","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1470-2045(13)70588-6","article-title":"Preferences for cancer investigation: a vignette-based study of primary-care attendees","volume":"15","author":"Banks","year":"2014","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.neurol.2026.01.002_bib0250","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00384-022-04240-5","article-title":"International expert opinion on optimal treatment of anastomotic leakage after rectal cancer resection: a case-vignette study","volume":"37","author":"Talboom","year":"2022","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"10.1016\/j.neurol.2026.01.002_bib0255","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2296-9-2","article-title":"Referring patients to specialists: a structured vignette survey of Australian and British GPs","volume":"9","author":"Jiwa","year":"2008","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.neurol.2026.01.002_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10194-020-01173-8","article-title":"The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study","volume":"21","author":"Silberstein","year":"2020","journal-title":"J Headache Pain"},{"issue":"20","key":"10.1016\/j.neurol.2026.01.002_bib0265","doi-asserted-by":"crossref","first-page":"e2309","DOI":"10.1212\/WNL.0000000000007497","article-title":"Erenumab in chronic migraine with medication overuse: subgroup analysis of a randomized trial","volume":"92","author":"Tepper","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2026.01.002_bib0270","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/0333102420966658","article-title":"Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine","volume":"41","author":"Dodick","year":"2021","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2026.01.002_bib0275","doi-asserted-by":"crossref","first-page":"1114654","DOI":"10.3389\/fneur.2023.1114654","article-title":"Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION\u00a0\u2013\u00a0a phase 4, multinational, randomized, double-blind, placebo-controlled study","volume":"14","author":"Jensen","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurol.2026.01.002_bib0280","unstructured":"H. Lundbeck A\/S. Clinicaltrials. gov. 2024 [cited 2024 July 15]. A study of eptinezumab in participants with migraine and medication overuse headache\u00a0\u2013\u00a0NCT05452239. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05452239?tab=results."},{"key":"10.1016\/j.neurol.2026.01.002_bib0285","unstructured":"Amgen. ClinicalTrials.Gov. 2024 [cited 2024 July 15]. A study to evaluate the efficacy and safety of erenumab in adults with medication overuse headache\u00a0\u2013\u00a0NCT03971071. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03971071."},{"issue":"3","key":"10.1016\/j.neurol.2026.01.002_bib0290","doi-asserted-by":"crossref","DOI":"10.1177\/03331024221150235","article-title":"Preventive CGRP-targeted therapies for chronic migraine with and without medication-overuse headache","volume":"43","author":"Alpuente","year":"2023","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.neurol.2026.01.002_bib0295","doi-asserted-by":"crossref","DOI":"10.1177\/03331024231170807","article-title":"Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study","volume":"43","author":"Ashina","year":"2023","journal-title":"Cephalalgia"},{"issue":"10","key":"10.1016\/j.neurol.2026.01.002_bib0300","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1007\/s10072-021-05105-5","article-title":"Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study","volume":"42","author":"Cainazzo","year":"2021","journal-title":"Neurol Sci"},{"issue":"8","key":"10.1016\/j.neurol.2026.01.002_bib0305","first-page":"670","article-title":"Guideline for primary care management of headache in adults","volume":"61","author":"Becker","year":"2015","journal-title":"Can Fam Physician"},{"issue":"9","key":"10.1016\/j.neurol.2026.01.002_bib0310","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1468-1331.2011.03497.x","article-title":"Treatment of medication overuse headache\u00a0\u2013\u00a0guideline of the EFNS headache panel","volume":"18","author":"Evers","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2026.01.002_bib0315","series-title":"Recommandations pour la pratique clinique. CCQ (C\u00e9phal\u00e9es chroniques quotidiennes)\u202f: diagnostic, r\u00f4le de l\u2019abus m\u00e9dicamenteux, prise en charge [Internet]","year":"2004"},{"issue":"11\u201312","key":"10.1016\/j.neurol.2026.01.002_bib0320","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1177\/03331024211018137","article-title":"CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: a systematic review and meta-analysis [Internet]","volume":"41","author":"Frank","year":"2021","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2026.01.002_bib0325","doi-asserted-by":"crossref","first-page":"1296577","DOI":"10.3389\/fphar.2023.1296577","volume":"14","author":"Corasaniti","year":"2023","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.neurol.2026.01.002_bib0330","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/head.13459","article-title":"Migraine progression: a systematic review","volume":"59","author":"Buse","year":"2019","journal-title":"Headache"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378726000202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378726000202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:23:46Z","timestamp":1774409026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378726000202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0035378726000202"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2026.01.002","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EPIGAME a vignette-based study of management practices of medication overuse in migraine, among French neurologists","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2026.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}